Tyvaso 64 MCG kit
Ended Awarded
- Contract number
- 36C24525N0839
- Awardee
-
United Therapeutics Corp UEI KK5FBFA43JS7
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $16,514
Award facts
- Contract value 100% obligated
- $16,514.15 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Bartlett, TN 38134, USA
Award details come from SAM.gov/FPDS.
About this award
This federal contract award was made by the Department of Veterans Affairs (VA) to United Therapeutics Corporation, a self-certified small disadvantaged business and for-profit manufacturer of pharmaceutical goods. The $16,514.15 firm fixed-price delivery order is for Tyvaso 64 MCG Kits, which are used to treat pulmonary arterial hypertension and certain cancer conditions.
The contract is associated with United Therapeutics' Federal Supply Schedule (FSS-61-IB) contract for Pharmaceuticals and Drugs. The company also holds a larger $207,127,385 Blanket Purchase Agreement (BPA) with the VA National Acquisition Center, which allows Veterans Integrated Service Networks to issue delivery orders for United Therapeutics' specialized pharmaceutical products, including Unituxin, Remodulin, Tyvaso, and Orenitram. This BPA supports the VA's mission of providing critical medical treatments to veterans across the country.
Quick answers
Who was awarded contract 36C24525N0839?
36C24525N0839 was awarded to United Therapeutics Corp by Veterans Integrated Service Network 5 (Veterans Health Administration) on August 3, 2025.
How much is contract 36C24525N0839 worth?
The government has obligated $16,514 on 36C24525N0839.
Is contract 36C24525N0839 an order under another contract?
Yes. 36C24525N0839 is a delivery order under 36F79720D0104, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24525N0839 competed?
The extent of competition for 36C24525N0839 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award